PR - Clinical Microbiomics acquires MS-Omics - Release 17.10.2022 | Seventure<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf\",\"url\":\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf\",\"name\":\"PR - Clinical Microbiomics acquires MS-Omics - Release 17.10.2022 | Seventure\",\"isPartOf\":{\"@id\":\"https:\/\/www.seventure.fr\/en\/#website\"},\"datePublished\":\"2022-10-17T11:19:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.seventure.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clinical Microbiomics adds metabolomics to its portfolio with acquisition of MS-Omics to form the leading multi-omics provider for the microbiome field.\",\"item\":\"https:\/\/www.seventure.fr\/en\/clinical-microbiomics-adds-metabolomics-to-its-portfolio-with-acquisition-of-ms-omics-to-form-the-leading-multi-omics-provider-for-the-microbiome-field\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"PR – Clinical Microbiomics acquires MS-Omics – Release 17.10.2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.seventure.fr\/en\/#website\",\"url\":\"https:\/\/www.seventure.fr\/en\/\",\"name\":\"Seventure\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.seventure.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n","yoast_head_json":{"title":"PR - Clinical Microbiomics acquires MS-Omics - Release 17.10.2022 | Seventure","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf","url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf","name":"PR - Clinical Microbiomics acquires MS-Omics - Release 17.10.2022 | Seventure","isPartOf":{"@id":"https:\/\/www.seventure.fr\/en\/#website"},"datePublished":"2022-10-17T11:19:34+00:00","breadcrumb":{"@id":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.seventure.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Clinical Microbiomics adds metabolomics to its portfolio with acquisition of MS-Omics to form the leading multi-omics provider for the microbiome field.","item":"https:\/\/www.seventure.fr\/en\/clinical-microbiomics-adds-metabolomics-to-its-portfolio-with-acquisition-of-ms-omics-to-form-the-leading-multi-omics-provider-for-the-microbiome-field\/"},{"@type":"ListItem","position":3,"name":"PR – Clinical Microbiomics acquires MS-Omics – Release 17.10.2022"}]},{"@type":"WebSite","@id":"https:\/\/www.seventure.fr\/en\/#website","url":"https:\/\/www.seventure.fr\/en\/","name":"Seventure","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.seventure.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"description":{"rendered":"<p class=\"attachment\"><a href='https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf'>PR - Clinical Microbiomics acquires MS-Omics - Release 17.10.2022<\/a><\/p>\n"},"caption":{"rendered":"<p>PR – Clinical Microbiomics acquires MS-Omics – Release 17.10.2022<\/p>\n"},"alt_text":"","media_type":"file","mime_type":"application\/pdf","media_details":{"filesize":59181,"sizes":{}},"post":7662,"source_url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf","_links":{"self":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/media\/7673","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/media"}],"about":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/types\/attachment"}],"author":[{"embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/comments?post=7673"}]}}

{"id":7673,"date":"2022-10-17T13:19:34","date_gmt":"2022-10-17T11:19:34","guid":{"rendered":"http:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf"},"modified":"2022-10-17T13:19:34","modified_gmt":"2022-10-17T11:19:34","slug":"pr-clinical-microbiomics-acquires-ms-omics-release-17-10-2022-6","status":"inherit","type":"attachment","link":"https:\/\/www.seventure.fr\/en\/clinical-microbiomics-adds-metabolomics-to-its-portfolio-with-acquisition-of-ms-omics-to-form-the-leading-multi-omics-provider-for-the-microbiome-field\/pr-clinical-microbiomics-acquires-ms-omics-release-17-10-2022-6\/","title":{"rendered":"PR – Clinical Microbiomics acquires MS-Omics – Release 17.10.2022"},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false},"class_list":["post-7673","attachment","type-attachment","status-inherit","hentry"],"acf":[],"yoast_head":"\nPR - Clinical Microbiomics acquires MS-Omics - Release 17.10.2022 | Seventure<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf\",\"url\":\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf\",\"name\":\"PR - Clinical Microbiomics acquires MS-Omics - Release 17.10.2022 | Seventure\",\"isPartOf\":{\"@id\":\"https:\/\/www.seventure.fr\/en\/#website\"},\"datePublished\":\"2022-10-17T11:19:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.seventure.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clinical Microbiomics adds metabolomics to its portfolio with acquisition of MS-Omics to form the leading multi-omics provider for the microbiome field.\",\"item\":\"https:\/\/www.seventure.fr\/en\/clinical-microbiomics-adds-metabolomics-to-its-portfolio-with-acquisition-of-ms-omics-to-form-the-leading-multi-omics-provider-for-the-microbiome-field\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"PR – Clinical Microbiomics acquires MS-Omics – Release 17.10.2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.seventure.fr\/en\/#website\",\"url\":\"https:\/\/www.seventure.fr\/en\/\",\"name\":\"Seventure\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.seventure.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n","yoast_head_json":{"title":"PR - Clinical Microbiomics acquires MS-Omics - Release 17.10.2022 | Seventure","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf","url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf","name":"PR - Clinical Microbiomics acquires MS-Omics - Release 17.10.2022 | Seventure","isPartOf":{"@id":"https:\/\/www.seventure.fr\/en\/#website"},"datePublished":"2022-10-17T11:19:34+00:00","breadcrumb":{"@id":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.seventure.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Clinical Microbiomics adds metabolomics to its portfolio with acquisition of MS-Omics to form the leading multi-omics provider for the microbiome field.","item":"https:\/\/www.seventure.fr\/en\/clinical-microbiomics-adds-metabolomics-to-its-portfolio-with-acquisition-of-ms-omics-to-form-the-leading-multi-omics-provider-for-the-microbiome-field\/"},{"@type":"ListItem","position":3,"name":"PR – Clinical Microbiomics acquires MS-Omics – Release 17.10.2022"}]},{"@type":"WebSite","@id":"https:\/\/www.seventure.fr\/en\/#website","url":"https:\/\/www.seventure.fr\/en\/","name":"Seventure","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.seventure.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"description":{"rendered":"<p class=\"attachment\"><a href='https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf'>PR - Clinical Microbiomics acquires MS-Omics - Release 17.10.2022<\/a><\/p>\n"},"caption":{"rendered":"<p>PR – Clinical Microbiomics acquires MS-Omics – Release 17.10.2022<\/p>\n"},"alt_text":"","media_type":"file","mime_type":"application\/pdf","media_details":{"filesize":59181,"sizes":{}},"post":7662,"source_url":"https:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/10\/PR-Clinical-Microbiomics-acquires-MS-Omics-Release-17.10.2022-5.pdf","_links":{"self":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/media\/7673","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/media"}],"about":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/types\/attachment"}],"author":[{"embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/comments?post=7673"}]}}